Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children
Open Access
- 25 October 2019
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 107 (5) , 1179-1188
Abstract
Poor adherence to seasonal malaria chemoprevention (SMC) might affect the protective effectiveness of SMC. Here, we evaluated the population pharmacokinetic properties of amodiaquine and its active metabolite, desethylamodiaquine, in children receiving SMC under directly observed ideal conditions (n = 136), and the adherence of SMC at an implementation phase in children participating in a case‐control study to evaluate SMC effectiveness (n = 869). Amodiaquine and desethylamodiaquine concentration‐time profiles were described simultaneously by two‐compartment and three‐compartment disposition models, respectively. The developed methodology to evaluate adherence showed a sensitivity of 65–71% when the first dose of SMC was directly observed and 71–73% when no doses were observed in a routine programmatic setting. Adherence simulations and measured desethylamodiaquine concentrations in the case‐control children showed complete adherence (all doses taken) in < 20% of children. This result suggests that more efforts are needed urgently to improve the adherence to SMC among children in this area.Keywords
Funding Information
- Doctors Without Borders
- Wellcome Trust
- Bill and Melinda Gates Foundation
This publication has 33 references indexed in Scilit:
- Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidenceMalaria Journal, 2014
- Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after PregnancyAntimicrobial Agents and Chemotherapy, 2012
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in MaliMalaria Journal, 2011
- Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, UgandaAntimicrobial Agents and Chemotherapy, 2010
- Population pharmacokinetics of artesunate and amodiaquine in African childrenMalaria Journal, 2009
- Effect of Concomitant Artesunate Administration and Cytochrome P4502C8 Polymorphisms on the Pharmacokinetics of Amodiaquine in Ghanaian Children with Uncomplicated MalariaAntimicrobial Agents and Chemotherapy, 2008
- Review: Intermittent preventive treatment – a new approach to the prevention of malaria in children in areas with seasonal malaria transmissionTropical Medicine & International Health, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005
- Drug Metabolism and Pharmacokinetics in Malnourished ChildrenClinical Pharmacokinetics, 1989